{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:15:55Z","timestamp":1787066155190,"version":"build-2736575974"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic cardiometabolic assaults during type 2 diabetes (T2D) and obesity induce a progenitor cell imbalance in the circulation characterized by overproduction and release of pro-inflammatory monocytes and granulocytes from the bone marrow alongside aberrant differentiation and mobilization of pro-vascular progenitor cells that generate downstream progeny for the coordination of blood vessel repair. This imbalance can be detected in the peripheral blood of individuals with established T2D and severe obesity using multiparametric flow cytometry analyses to discern pro-inflammatory vs. pro-angiogenic progenitor cell subsets identified by high aldehyde dehydrogenase activity, a conserved progenitor cell protective function, combined with lineage-restricted cell surface marker analyses. Recent evidence suggests that progenitor cell imbalance can be reversed by treatment with pharmacological agents or surgical interventions that reduce hyperglycaemia or excess adiposity. In this state-of-the-art review, we present current strategies to assess the progression of pro-vascular regenerative cell depletion in peripheral blood samples of individuals with T2D and obesity and we summarize novel clinical data that intervention using sodium-glucose co-transporter 2 inhibition or gastric bypass surgery can efficiently restore cell-mediated vascular repair mechanisms associated with profound cardiovascular benefits in recent outcome trials. Collectively, this thesis generates a compelling argument for early intervention using current pharmacological agents to prevent or restore imbalanced circulating progenitor content and maintain vascular regenerative cell trafficking to sites of ischaemic damage. This conceptual advancement may lead to the design of novel therapeutic approaches to prevent or reverse the devastating cardiovascular comorbidities currently associated with T2D and obesity.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehab758","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T07:11:11Z","timestamp":1634800271000},"page":"450-459","source":"Crossref","is-referenced-by-count":28,"title":["Vascular repair and regeneration in cardiometabolic diseases"],"prefix":"10.1093","volume":"43","author":[{"given":"David A","family":"Hess","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Toronto , 27 King's College Circle , Toronto, ON M5S 3J3, Canada"},{"name":"Division of Vascular Surgery, St. Michael's Hospital , 30 Bond Street , Toronto, ON M5B 1W8, Canada"},{"name":"Molecular Medicine Research Laboratories, Krembil Centre for Stem Cells Biology, Robarts Research Institute, University of Western Ontario , 1151 Richmond Street North , London, ON N6H 0E8, Canada"},{"name":"Department of Physiology and Pharmacology, University of Western Ontario , 1151 Richmond Street North , London, ON N6H 0E8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Toronto , 27 King's College Circle , Toronto, ON M5S 3J3, Canada"},{"name":"Division of Cardiovascular Surgery, St. Michael's Hospital , 30 Bond Street , Toronto, ON M5B 1W8, Canada"},{"name":"Institute of Medical Sciences, University of Toronto , 27 King's College Circle , Toronto, ON M5S 3J3, Canada"},{"name":"Department of Surgery, University of Toronto , 27 King's College Circle , Toronto, ON M5S 3J3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Harvard Medical School , Brigham and Women's Hospital, 75 Francis Street , Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4687-6553","authenticated-orcid":false,"given":"Ehab","family":"Bakbak","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Toronto , 27 King's College Circle , Toronto, ON M5S 3J3, Canada"},{"name":"Division of Cardiovascular Surgery, St. Michael's Hospital , 30 Bond Street , Toronto, ON M5B 1W8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella C","family":"Terenzi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, St. Michael's Hospital , 30 Bond Street , Toronto, ON M5B 1W8, Canada"},{"name":"Institute of Medical Sciences, University of Toronto , 27 King's College Circle , Toronto, ON M5S 3J3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Puar","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, St. Michael's Hospital , 30 Bond Street , Toronto, ON M5B 1W8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6967-5685","authenticated-orcid":false,"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital , Stockholm SE171 77, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"2022102517143668200_ehab758-B1","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1016\/S2214-109X(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","author":"Kaptoge","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2022102517143668200_ehab758-B2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"2022102517143668200_ehab758-B4","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe - Epidemiological update 2015","volume":"36","author":"Townsend","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102517143668200_ehab758-B5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","article-title":"Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism","volume":"113","author":"Poirier","year":"2006","journal-title":"Circulation"},{"key":"2022102517143668200_ehab758-B6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S2213-8587(17)30097-9","article-title":"The global economic burden of diabetes in adults aged 20\u201379 years: a cost-of-illness study","volume":"5","author":"Bommer","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022102517143668200_ehab758-B7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1464-5491.2012.03698.x","article-title":"Estimating the current and future costs of Type1 and Type2 diabetes in the UK, including direct health costs and indirect societal and productivity costs","volume":"29","author":"Hex","year":"2012","journal-title":"Diabet Med"},{"key":"2022102517143668200_ehab758-B8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2019.11.044","article-title":"Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review","volume":"75","author":"Mechanick","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102517143668200_ehab758-B9","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"key":"2022102517143668200_ehab758-B10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurheartj\/ehx615","article-title":"Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity","volume":"40","author":"Costantino","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102517143668200_ehab758-B11","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.2337\/db17-0294","article-title":"Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with type 2 diabetes and with target HbA1c levels","volume":"66","author":"Costantino","year":"2017","journal-title":"Diabetes"},{"key":"2022102517143668200_ehab758-B12","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/CIRCRESAHA.120.317132","article-title":"Hyperglycemia induces myocardial dysfunction via epigenetic regulation of JunD","volume":"127","author":"Hussain","year":"2020","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/eurheartj\/ehu179","article-title":"Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes","volume":"36","author":"Paneni","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102517143668200_ehab758-B14","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780198755777.001.0001","volume-title":"ESC Textbook of Vascular Biology","author":"Krams","year":"2017"},{"key":"2022102517143668200_ehab758-B15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molmed.2019.03.006","article-title":"Vascular regenerative cell exhaustion in diabetes: translational opportunities to mitigate cardiometabolic risk","volume":"25","author":"Terenzi","year":"2019","journal-title":"Trends Mol Med"},{"key":"2022102517143668200_ehab758-B16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"2022102517143668200_ehab758-B17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI6889","article-title":"Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization","volume":"103","author":"Isner","year":"1999","journal-title":"J Clin Invest"},{"key":"2022102517143668200_ehab758-B18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"2022102517143668200_ehab758-B19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2022102517143668200_ehab758-B20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cell.2005.12.023","article-title":"An SDF-1 trap for myeloid cells stimulates angiogenesis","volume":"124","author":"Ruiz De Almodovar","year":"2006","journal-title":"Cell"},{"key":"2022102517143668200_ehab758-B21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B22","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"2022102517143668200_ehab758-B24","doi-asserted-by":"crossref","first-page":"e0205851","DOI":"10.1371\/journal.pone.0205851","article-title":"Circulating angiogenic stem cells in type 2 diabetes are associated with glycemic control and endothelial dysfunction","volume":"13","author":"Zafar","year":"2018","journal-title":"PLoS One"},{"key":"2022102517143668200_ehab758-B25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","article-title":"Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus","volume":"45","author":"Fadini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2022102517143668200_ehab758-B26","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/eurheartj\/ehl198","article-title":"Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk","volume":"27","author":"Fadini","year":"2006","journal-title":"Eur Heart J"},{"key":"2022102517143668200_ehab758-B27","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1210\/jc.2015-2867","article-title":"Circulating stem cells associate with adiposity and future metabolic deterioration in healthy subjects","volume":"100","author":"Fadini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102517143668200_ehab758-B28","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1093\/eurheartj\/ehz923","article-title":"Circulating stem cells and cardiovascular outcomes: from basic science to the clinic","volume":"41","author":"Fadini","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102517143668200_ehab758-B29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1084\/jem.20050967","article-title":"Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates","volume":"202","author":"Passegu\u00e9","year":"2005","journal-title":"J Exp Med"},{"key":"2022102517143668200_ehab758-B30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(00)00025-8","article-title":"A role for hematopoietic stem cells in promoting angiogenesis","volume":"102","author":"Takakura","year":"2000","journal-title":"Cell"},{"key":"2022102517143668200_ehab758-B31","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.CIR.0000096483.29777.50","article-title":"Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells","volume":"108","author":"Urbich","year":"2003","journal-title":"Circulation"},{"key":"2022102517143668200_ehab758-B32","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","article-title":"Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals","volume":"109","author":"Yoder","year":"2007","journal-title":"Blood"},{"key":"2022102517143668200_ehab758-B33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/hh2101.098613","article-title":"Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit","volume":"89","author":"Deindl","year":"2001","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.ATV.0000203513.29227.6f","article-title":"Differential healing activities of CD34+ and CD14+ endothelial cell progenitors","volume":"26","author":"Awad","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517143668200_ehab758-B35","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1096\/fj.02-0172fje","article-title":"Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha\/VEGF pathway","volume":"17","author":"Michaud","year":"2003","journal-title":"FASEB J"},{"key":"2022102517143668200_ehab758-B36","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.ATV.0000171994.89106.ca","article-title":"Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network","volume":"25","author":"Schiekofer","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517143668200_ehab758-B37","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.2337\/db08-0229","article-title":"Impaired collateral recruitment and outward remodeling in experimental diabetes","volume":"57","author":"Van Golde","year":"2008","journal-title":"Diabetes"},{"key":"2022102517143668200_ehab758-B38","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jvs.2009.08.007","article-title":"Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells","volume":"50","author":"Yan","year":"2009","journal-title":"J Vasc Surg"},{"key":"2022102517143668200_ehab758-B39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage Polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"2022102517143668200_ehab758-B40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1570161111309010005","article-title":"The temporal and spatial distribution of macrophage subpopulations during arteriogenesis","volume":"11","author":"Troidl","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"2022102517143668200_ehab758-B41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature10507","article-title":"Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis","volume":"479","author":"Takeda","year":"2011","journal-title":"Nature"},{"key":"2022102517143668200_ehab758-B42","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/stem.2612","article-title":"High aldehyde dehydrogenase activity identifies a subset of human mesenchymal stromal cells with vascular regenerative potential","volume":"35","author":"Sherman","year":"2017","journal-title":"Stem Cells"},{"key":"2022102517143668200_ehab758-B43","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/sctm.16-0472","article-title":"Expansion of umbilical cord blood aldehyde dehydrogenase expressing cells generates myeloid progenitor cells that stimulate limb revascularization","volume":"6","author":"Putman","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"2022102517143668200_ehab758-B44","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/stem.1206","article-title":"Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury","volume":"30","author":"Putman","year":"2012","journal-title":"Stem Cells"},{"key":"2022102517143668200_ehab758-B45","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.1073\/pnas.96.16.9118","article-title":"Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity","volume":"96","author":"Storms","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022102517143668200_ehab758-B46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1182\/blood-2004-09-3652","article-title":"Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34","volume":"106","author":"Storms","year":"2005","journal-title":"Blood"},{"key":"2022102517143668200_ehab758-B47","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-02-0448","article-title":"Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity","volume":"104","author":"Hess","year":"2004","journal-title":"Blood"},{"key":"2022102517143668200_ehab758-B48","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-06-2284","article-title":"Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells","volume":"107","author":"Hess","year":"2006","journal-title":"Blood"},{"key":"2022102517143668200_ehab758-B49","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1182\/blood-2008-04-154567","article-title":"Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity","volume":"113","author":"Capoccia","year":"2009","journal-title":"Blood"},{"key":"2022102517143668200_ehab758-B50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ccd.23066","article-title":"A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia","volume":"78","author":"Perin","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022102517143668200_ehab758-B51","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.116.025707","article-title":"Evaluation of cell therapy on exercise performance and limb perfusion in peripheral artery disease: the CCTRN PACE Trial (Patients with Intermittent Claudication Injected with ALDH Bright Cells)","volume":"135","author":"Perin","year":"2017","journal-title":"Circulation"},{"key":"2022102517143668200_ehab758-B52","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/sctm.16-0472","article-title":"Expansion of umbilical cord blood aldehyde dehydrogenase expressing cells generates myeloid progenitor cells that stimulate limb revascularization","volume":"6","author":"Putman","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"2022102517143668200_ehab758-B53","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1242\/dev.106575","article-title":"The analysis, roles and regulation of quiescence in hematopoietic stem cells","volume":"141","author":"Nakamura-Ishizu","year":"2014","journal-title":"Development"},{"key":"2022102517143668200_ehab758-B54","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s00125-006-0401-6","article-title":"Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats","volume":"49","author":"Fadini","year":"2006","journal-title":"Diabetologia"},{"key":"2022102517143668200_ehab758-B55","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.ATV.0000237750.44469.88","article-title":"Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy","volume":"26","author":"Fadini","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517143668200_ehab758-B56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cjca.2012.04.003","article-title":"Linking diabetes with oxidative stress, adipokines, and impaired endothelial precursor cell function","volume":"28","author":"Hess","year":"2012","journal-title":"Can J Cardiol"},{"key":"2022102517143668200_ehab758-B57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.atherosclerosis.2010.01.036","article-title":"Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk","volume":"211","author":"Jialal","year":"2010","journal-title":"Atherosclerosis"},{"key":"2022102517143668200_ehab758-B58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/stem.2751","article-title":"Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies","volume":"36","author":"Qadura","year":"2018","journal-title":"Stem Cells"},{"key":"2022102517143668200_ehab758-B59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jacbts.2018.10.005","article-title":"Circulating pro-vascular progenitor cell depletion during type 2 diabetes","volume":"4","author":"Terenzi","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2022102517143668200_ehab758-B60","doi-asserted-by":"crossref","first-page":"A228","DOI":"10.1161\/res.127.suppl_1.228","article-title":"Inflammasome-primed neutrophils return to the bone marrow to stimulate leukocytosis following myocardial infarction","volume":"127","author":"Nagareddy","year":"2020","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCULATIONAHA.120.046038","article-title":"Bone marrow endothelial cells regulate myelopoiesis in diabetes mellitus","volume":"142","author":"Hoyer","year":"2020","journal-title":"Circulation"},{"key":"2022102517143668200_ehab758-B62","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cmet.2014.03.029","article-title":"Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity","volume":"19","author":"Nagareddy","year":"2014","journal-title":"Cell Metab"},{"key":"2022102517143668200_ehab758-B63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrendo.2011.243","article-title":"SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects","volume":"8","author":"Ferrannini","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"2022102517143668200_ehab758-B64","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2022102517143668200_ehab758-B65","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/stem.1659","article-title":"Switch from canonical to noncanonical Wnt signaling mediates high glucose-induced adipogenesis","volume":"32","author":"Keats","year":"2014","journal-title":"Stem Cells"},{"key":"2022102517143668200_ehab758-B66","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cmet.2019.08.015","article-title":"SGLT2 inhibition with empagliflozin increases circulating provascular progenitor cells in people with type 2 diabetes mellitus","volume":"30","author":"Hess","year":"2019","journal-title":"Cell Metab"},{"key":"2022102517143668200_ehab758-B67","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2018-00824","article-title":"Effects of SGLT2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes","volume":"103","author":"Bonora","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102517143668200_ehab758-B68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2019.11.044","article-title":"Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review","volume":"75","author":"Mechanick","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102517143668200_ehab758-B69","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes \u2014 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102517143668200_ehab758-B70","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/dc16-0157","article-title":"Clinical outcomes of metabolic surgery: microvascular and macrovascular complications","volume":"39","author":"Adams","year":"2016","journal-title":"Diabetes Care"},{"key":"2022102517143668200_ehab758-B71","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.xcrm.2020.100018","article-title":"Vascular risk reduction in obesity through reduced granulocyte burden and improved angiogenic monocyte content following bariatric surgery","volume":"1","author":"Hess","year":"2020","journal-title":"Cell Reports Med"},{"key":"2022102517143668200_ehab758-B72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/ATVBAHA.119.312863","article-title":"Impaired regeneration contributes to poor outcomes in diabetic peripheral artery disease","volume":"40","author":"Fadini","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517143668200_ehab758-B73","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-1084","article-title":"Diabetes impairs stem cell and proangiogenic cell mobilization in humans","volume":"36","author":"Fadini","year":"2013","journal-title":"Diabetes Care"},{"key":"2022102517143668200_ehab758-B74","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMcibr1112347","article-title":"Diabetic stem-cell \u201cmobilopathy\u201d","volume":"365","author":"DiPersio","year":"2011","journal-title":"N Engl J Med"},{"key":"2022102517143668200_ehab758-B75","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/db19-0080","article-title":"Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway","volume":"68","author":"Albiero","year":"2019","journal-title":"Diabetes"},{"key":"2022102517143668200_ehab758-B76","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00125-020-05142-3","article-title":"Diabetes mellitus impairs circulating proangiogenic granulocytes","volume":"63","author":"Cappellari","year":"2020","journal-title":"Diabetologia"},{"key":"2022102517143668200_ehab758-B77","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/db20-1045","article-title":"Inhibition of SGLT-2 rescues bone marrow cell traffic for vascular repair. Role of glucose control and ketogenesis","volume":"70","author":"Albiero","year":"2021","journal-title":"Diabetes"},{"key":"2022102517143668200_ehab758-B78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00395-012-0313-1","article-title":"Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy","volume":"108","author":"Fadini","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"2022102517143668200_ehab758-B79","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/db19-0640","article-title":"Pharmacologic PPAR-\u03b3 activation reprograms bone marrow macrophages and partially rescues HSPC mobilization in human and murine diabetes","volume":"69","author":"Tedesco","year":"2020","journal-title":"Diabetes"},{"key":"2022102517143668200_ehab758-B80","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11695-017-2913-1","article-title":"A meta-analysis of GLP-1 after Roux-En-Y gastric bypass: impact of surgical technique and measurement strategy","volume":"28","author":"Jirapinyo","year":"2018","journal-title":"Obes Surg"},{"key":"2022102517143668200_ehab758-B81","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody","volume":"155","author":"Pyke","year":"2014","journal-title":"Endocrinology"},{"key":"2022102517143668200_ehab758-B82","first-page":"BR35","article-title":"Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation","volume":"17","author":"Xie","year":"2011","journal-title":"Med Sci Monit"},{"key":"2022102517143668200_ehab758-B83","doi-asserted-by":"crossref","first-page":"e006394","DOI":"10.1161\/JAHA.117.006394","article-title":"Dipeptidyl peptidase-4 regulates hematopoietic stem cell activation in response to chronic stress","volume":"6","author":"Zhu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022102517143668200_ehab758-B84","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.7150\/ijbs.27774","article-title":"GLP-1 treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction","volume":"14","author":"Cai","year":"2018","journal-title":"Int J Biol Sci"},{"key":"2022102517143668200_ehab758-B85","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/atv.0000615456.97862.30","article-title":"Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension","volume":"40","author":"Helmst\u00e4dter","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517143668200_ehab758-B86","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09669-7","article-title":"Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?","author":"Bakbak","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"2022102517143668200_ehab758-B87","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102517143668200_ehab758-B88","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"LEADER steering committee; leader trial investigators. liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102517143668200_ehab758-B89","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/CIRCRESAHA.117.309681","article-title":"Extracellular vesicles in angiogenesis","volume":"120","author":"Todorova","year":"2017","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B90","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.116.310557","article-title":"Angiogenic mechanisms of human CD34+stem cell exosomes in the repair of ischemic hindlimb","volume":"120","author":"Mathiyalagan","year":"2017","journal-title":"Circ Res"},{"key":"2022102517143668200_ehab758-B91","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2013-02-478925","article-title":"Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells","volume":"121","author":"van Balkom","year":"2013","journal-title":"Blood"},{"key":"2022102517143668200_ehab758-B92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0895-0","article-title":"MiR-10a rejuvenates aged human mesenchymal stem cells and improves heart function after myocardial infarction through KLF4","volume":"9","author":"Dong","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"2022102517143668200_ehab758-B93","doi-asserted-by":"crossref","first-page":"18277","DOI":"10.1038\/srep18277","article-title":"A YAP\/TAZ-miR-130\/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions","volume":"5","author":"Bertero","year":"2015","journal-title":"Sci Rep"},{"key":"2022102517143668200_ehab758-B94","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2022102517143668200_ehab758-B95","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-17437-2","volume-title":"Cardiac Fibrosis and Heart Failure: Cause or Effect?","author":"Dixon","year":"2015"},{"key":"2022102517143668200_ehab758-B96","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.stem.2019.12.012","article-title":"Tissue-engineered vascular grafts with advanced mechanical strength from human iPSCs","volume":"26","author":"Luo","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2022102517143668200_ehab758-B97","first-page":"394","article-title":"Role of prosthetic conduits in coronary artery bypass grafting","volume":"40","author":"Desai","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022102517143668200_ehab758-B98","doi-asserted-by":"crossref","first-page":"68ra9","DOI":"10.1126\/scitranslmed.3001426","article-title":"Readily available tissue-engineered vascular grafts","volume":"3","author":"Dahl","year":"2011","journal-title":"Sci Transl Med"},{"key":"2022102517143668200_ehab758-B99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tcm.2012.03.004","article-title":"Bioengineered vascular grafts: can we make them off-the-shelf?","volume":"21","author":"Dahl","year":"2011","journal-title":"Trends Cardiovasc Med"},{"key":"2022102517143668200_ehab758-B100","doi-asserted-by":"crossref","first-page":"I159","DOI":"10.1161\/CIRCULATIONAHA.105.001172","article-title":"Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model","volume":"114","author":"Hoerstrup","year":"2006","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/6\/450\/46629917\/ehab758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/6\/450\/46629917\/ehab758.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T14:21:49Z","timestamp":1666707709000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/6\/450\/6438181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":100,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,11,24]]},"published-print":{"date-parts":[[2022,2,10]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab758","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,7]]},"published":{"date-parts":[[2021,11,24]]}}}